Sending Office: Honorable Tulsi Gabbard
Sent By:
Patrick.Koetzle@mail.house.gov

MARIJUANA DATA COLLECTION ACT

 

Endorsed By: NORML, the National Cannabis Industry Association (NCIA), Minority Cannabis Business Association (MCBA), Drug Policy Alliance, Students for Sensible Drug Policy, Americans for Safe Access, and the Veterans Cannabis Coalition

 

Purpose: A bill to create a federally recognized report by a neutral arbitrator on the status of state-legal marijuana programs, both medical and non-medical use. This is necessary since one of the most repeated points about marijuana policy is that
the data does not exist. Rather, it is the federal government largely refuses to acknowledge the state-or private organization-led prepared reports on the impacts of state-level regulated markets. 

Background: Several studies by prominent healthcare associations or publications have produced data that looks into states that have legalized marijuana and the benefits legalization has produced for the state from an economic, criminal justice, and
healthcare perspective, among others. Despite these reports, marijuana remains a controversial topic, fueled by its misplaced stigma, and the “war on drugs” rhetoric from various prominent law enforcement officials. Recently, President Trump stood by his original
position to allow states to continue to go without federal interference, but authorizing legislation that would deschedule, or allow research for medical and/or non-medicinal marijuana has yet to advance in Congress.

Goal: The purpose of this legislation is to collect and synthesize relevant data and to generate a federally recognized, neutral report regarding the impact of statewide marijuana legalization schemes. Such a report will assure that federal discussions
and policies specific to this issue are based upon the best and most reliable evidence available at this time.

Bill Overview:

  • The purpose of this bill is to require a study on the effects of state legalized marijuana programs – both medicinal and non-medicinal – in correlation with several aspects of legalization, from state revenues, public health, substance abuse and opioids,
    criminal justice, and employment.
  • Specifically, this bill requires the Secretary of HHS to coordinate with the DOJ, DOL, and States (to the greatest extent possible) and direct the National Academy of Sciences (NAS) to publish a biannual study on the effects of state legalized marijuana
    programs on revenues and state allocations, public health, substance use, criminal justice, and employment.
  • The Report also will include a section outlining best practices by states for data collection, as well as outline any barriers preventing data collection and any gaps in data, explaining how to overcome these barriers and gaps in future studies.

For more information, or if you would like to cosponsor the Marijuana Data Collection Act, please contact Patrick Koetzle (patrick.koetzle@mail.house.gov) with Rep. Gabbard or Jesse Von
Stein (jesse.vonstein@mail.house.gov) with Rep. Young.

Related Legislative Issues

Selected legislative information: Education, Environment, Finance, HealthCare, Judiciary, Labor, Veterans

icon eDC logo e-Dear Colleague version 2.0
 
e-Dear Colleagues are intended for internal House use only.